10q10k10q10k.net
BIOHARVEST SCIENCES INC.

BIOHARVEST SCIENCES INC.BHSTEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.

Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024

Revenue

$8.1M

Gross Profit

$4.8M

Operating Profit

N/A

Net Profit

N/A

Gross Margin

60.0%

Operating Margin

N/A

Net Margin

N/A

YoY Growth

N/A

BIOHARVEST SCIENCES INC. Q2 FY2025 Financial Summary

BIOHARVEST SCIENCES INC. reported revenue of $8.1M for Q2 FY2025, with a net profit of N/A (N/A margin). Cost of goods sold was $3.2M.

Key Financial Metrics

Total Revenue$8.1M
Net ProfitN/A
Gross Margin60.0%
Operating MarginN/A
Report PeriodQ2 FY2025

Revenue Breakdown

BIOHARVEST SCIENCES INC. Q2 FY2025 revenue of $8.1M breaks down across 5 segments, led by Cost of revenues at $3.2M (40.0% of total).

SegmentRevenue% of Total
Cost of revenues$3.2M40.0%
Finance expense, net$2.2M27.6%
Other$1.6M19.6%
Research and development$988.0K12.3%
Tax expenses$39.0K0.5%

BIOHARVEST SCIENCES INC. Quarterly Revenue & Net Profit History

BIOHARVEST SCIENCES INC. results over the last 5 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q3 FY2025$8.4M—N/AN/A
Q2 FY2025$8.1M—N/AN/A
Q1 FY2025$7.7M—N/AN/A
Q3 FY2024$6.5M—N/AN/A
Q2 FY2024$6.0M—N/AN/A

Income Statement

Q2 2024Q3 2024Q1 2025Q2 2025Q3 2025
Revenue$6.0M$6.5M$7.7M$8.1M$8.4M
YoY GrowthN/AN/AN/AN/AN/A

Balance Sheet

Q2 2024Q3 2024Q1 2025Q2 2025Q3 2025
AssetsN/AN/AN/AN/AN/A
LiabilitiesN/AN/AN/AN/AN/A
EquityN/AN/AN/AN/AN/A

Cash Flow

No data available for this period